4.6 Article

Virulence genes and subclone status as markers of experimental virulence in a murine sepsis model among Escherichia coli sequence type 131 clinical isolates from Spain

期刊

PLOS ONE
卷 12, 期 11, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0188838

关键词

-

资金

  1. Instituto de Salud Carlos III of Spain [PI13/02092]
  2. Spanish Network for Research in Infectious Diseases or REIPI [RD12/0015/0004, RD16/0016/0011]
  3. European Development Regional Fund (ERDF)
  4. REIPI [RD12/0015/0004]
  5. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Ayuda a la formacion de la SEIMC, IMV)
  6. Office of Research and Development, Medical Research Service, Department of Veterans Affairs [1 I01 CX000192 01]

向作者/读者索取更多资源

Objective To assess experimental virulence among sequence type 131 (ST131) Escherichia coli bloodstream isolates in relation to virulence genotype and subclone. Methods We analysed 48 Spanish ST131 bloodstream isolates (2010) by PCR for ST131 subclone status (H30Rx, H30 non-Rx, or non-H30), virulence genes (VGs), and O-type. Then we compared these traits with virulence in a murine sepsis model, as measured by illness severity score (ISS) and rapid lethality (mean ISS >= 4). Results Of the 48 study isolates, 65% were H30Rx, 21% H30 non-Rx, and 15% non-H30; 44% produced ESBLs, 98% were O25b, and 83% qualified as extraintestinal pathogenic E. coli (ExPEC). Of 49 VGs, ibeA and iss were associated significantly with non-H30 isolates, and sat, iha and malX with H30 isolates. Median VG scores differed by subclone, i.e., 12 (H30Rx), 10 (H30 non-Rx), and 11 (non-H30) (p < 0.01). Nearly 80% of isolates represented a described virotype. In mice, H30Rx and non-H30 isolates were more virulent than H30 non-Rx isolates (according to ISS [p = 0.03] and rapid lethality [p = 0.03]), as were ExPEC isolates compared with non-ExPEC isolates (median ISS, 4.3 vs. 2.7: p = 0.03). In contrast, most individual VGs, VG scores, VG profiles, and virotypes were not associated with mouse virulence. Conclusions ST131 subclone and ExPEC status, but not individual VGs, VG scores or profiles, or virotypes, predicted mouse virulence. Given the lower virulence of non-Rx H30 isolates, hyper-virulence probably cannot explain the ST131-H30 clade's epidemic emergence.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Public, Environmental & Occupational Health

Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS

Daniel Prieto-Alhambra, Kristin Kostka, Talita Duarte-Salles, Albert Prats-Uribe, Anthony Sena, Andrea Pistillo, Sara Khalid, Lana Lai, Asieh Golozar, Thamir M. Alshammari, Dalia Dawoud, Fredrik Nyberg, Adam Wilcox, Alan Andryc, Andrew Williams, Anna Ostropolets, Carlos Areia, Chi Young Jung, Christopher Harle, Christian Reich, Clair Blacketer, Daniel Morales, David A. Dorr, Edward Burn, Elena Roel, Eng Hooi Tan, Evan Minty, Frank DeFalco, Gabriel de Maeztu, Gigi Lipori, Heba Alghoul, Hong Zhu, Jason Thomas, Jiang Bian, Jimyung Park, Jordi Martinez Roldan, Jose Posada, Juan M. Banda, Juan P. Horcajada, Julianna Kohler, Karishma Shah, Karthik Natarajan, Kristine Lynch, Li Liu, Lisa Schilling, Martina Recalde, Matthew Spotnitz, Mengchun Gong, Michael Matheny, Neus Valveny, Nicole Weiskopf, Nigam Shah, Osaid Alser, Paula Casajust, Rae Woong Park, Robert Schuff, Sarah Seager, Scott DuVall, Seng Chan You, Seokyoung Song, Sergio Fernandez-Bertolin, Stephen Fortin, Tanja Magoc, Thomas Falconer, Vignesh Subbian, Vojtech Huser, Waheed-Ul-Rahman Ahmed, William Carter, Yin Guan, Yankuic Galvan, Xing He, Peter Rijnbeek, George Hripcsak, Patrick Ryan, Marc Suchard, Daniel Prieto-Alhambra

Summary: This study utilizes the Observational Health Data Sciences and Informatics (OHDSI) framework to standardize and analyze real-world data on COVID-19. The findings reveal global variations in comorbidities, symptoms, and clinical presentations among patients. The study provides a global, multi-center perspective on the progression, management, and evolution of COVID-19.

CLINICAL EPIDEMIOLOGY (2022)

Editorial Material Infectious Diseases

Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP

Emilia Cercenado, Jesus Rodriguez-Bano, Jose Luis Alfonso, Esther Calbo, Luis Escosa, Aurora Fernandez-Polo, Julio Garcia-Rodriguez, Jose Garnacho, Maria Victoria Gil-Navarro, Santiago Grau, Carlota Gudiol, Juan Pablo Horcajada, Nieves Larrosa, Carmen Martinez, Jose Molina, Xavier Nuvials, Antonio Oliver, Jose Ramon Pano-Pardo, Maria Teresa Perez-Rodriguez, Paula Ramirez, Pedro Rey-Biel, Pablo Vidal, Pilar Retamar-Gentil

Summary: In 2012, consensus recommendations were published by multiple Spanish societies on the implementation of antimicrobial stewardship (AMS) programs in acute care hospitals. However, there was a need for further guidance on AMS activities for specific patient populations or circumstances. Therefore, a panel of experts was assembled to review available information and provide guidance recommendations on these topics.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2023)

Article Immunology

The Impact of Colistin Resistance on the Activation of Innate Immunity by Lipopolysaccharide Modification

Jose Avendano-Ortiz, Manuel Ponce-Alonso, Emilio Llanos-Gonzalez, Hugo Barragan-Prada, Raquel Barbero-Herranz, Roberto Lozano-Rodriguez, Francesc J. Marquez-Garrido, Jose Maria Hernandez-Perez, Maria-Isabel Morosini, Rafael Canton, Rosa del Campo, Eduardo Lopez-Collazo

Summary: We investigated the effects of different lipopolysaccharide (LPS) modifications on colistin resistance and found that adding Ara4N to LPS increases the survival of Klebsiella pneumoniae in the human body and elicits a stronger inflammatory response.

INFECTION AND IMMUNITY (2023)

Article Infectious Diseases

Pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections

D. Fresan, S. Luque, A. Benitez-Cano, L. Sorli, M. Milagro Montero, M. De-Antonio, N. Prim, V. Vega, J. P. Horcajada, S. Grau

Summary: Administering ceftazidime/avibactam by continuous infusion can achieve the desired drug concentration and therapeutic target in most patients, even at lower doses. The combination of continuous infusion and therapeutic drug monitoring can be a useful tool for reducing antimicrobial-related adverse effects and treatment costs.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Microbiology

Antimicrobial resistance in Gram-negative bacilli in Spain: an experts' view

Pilar Retamar-Gentil, Rafael Canton, Vicente Abril Lopez de Medrano, Jose Barberan, Andres Canut Blasco, Carlos Duenas Gutierrez, Carolina Garcia-Vidal, Nieves Larrosa Escartin, Jaime Lora-Tamayo, Francisco Javier Martinez Marcos, Carlos Martin Ruiz, Juan Pasquau Liano, Pedro Rascado, Oscar Sanz Pelaez, Genoveva Yague Girao, Juan P. Horcajada

Summary: This work presents the views of a group of experts on resistance to antimicrobial agents in Gram-negative bacilli, including the current epidemiology, its relation to clinical practice, and new therapies based on evidence. After reviewing the most relevant evidence, data on these aspects were presented to experts in infectious diseases, clinical microbiology, internal medicine, intensive care medicine, anaesthesiology, and hospital pharmacy, leading to conclusions on the matter.

REVISTA ESPANOLA DE QUIMIOTERAPIA (2023)

Article Multidisciplinary Sciences

Evaluation of the host immune response assay SeptiCyte RAPID for potential triage of COVID-19 patients

Maria Milagro Montero, Max Hardy-Werbin, Soledad Gonzalez-Gallardo, Erica Torres, Rebeca Rueda, Irene Hannet, James T. Kirk, Thomas D. Yager, Krupa Navalkar, Maria del Mar Arenas, Itziar Arietta-Aldea, Silvia Castaneda, Joan Gomez-Junyent, Silvia Gomez-Zorrilla, Roberto Guerri-Fernandez, Francisca Sanchez-Martinez, Immaculada Lopez-Montesinos, Ivan Pelegrin, Elena Sendra, Luisa Sorli, Judith Villar-Garcia, Beatriz Bellosillo, Juan Pablo Horcajada

Summary: Evaluation of SeptiCyte RAPID as a triaging tool for COVID-19 patients found that it can stratify cases according to clinical severity. The tool showed better discrimination than other biomarkers in predicting the need for ICU admission in COVID-19 patients.

SCIENTIFIC REPORTS (2023)

Review Infectious Diseases

Ampicillin-resistant and vancomycin-susceptible Enterococcus faecium bacteremia: a clinical narrative review

Daniel Echeverria-Esnal, Luisa Sorli, Maria Eugenia Navarrete-Rouco, Nuria Prim, Jaime Barcelo-Vidal, David Conde-Estevez, Maria Milagro Montero, Clara Martin-Ontiyuelo, Juan Pablo Horcajada, Santiago Grau

Summary: This article reviews the relevant aspects of ampicillin-resistant and vancomycin-susceptible Enterococcus faecium (EfARSV) bacteremia, including microbiology, gastrointestinal tract colonization and invasion, antibiotic resistance, epidemiology, risk factors, mortality, and treatment. However, the most appropriate treatment for this infection remains uncertain due to limited data.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2023)

Article Public, Environmental & Occupational Health

Quantification of time delay between screening and subsequent initiation of contact isolation for carriers of extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales: A post hoc subgroup analysis of the R-GNOSIS WP5 Trial

Friederike Maechler, Frank Schwab, Sonja Hansen, Michael Behnke, Marc J. Bonten, Rafael Canton, Cristina Diaz Agero, Carolina Fankhauser, Stephan Harbarth, Benedikt D. Huttner, Axel Kola, Petra Gastmeier

Summary: This study aimed to quantify the time delay between screening and initiation of contact isolation for carriers of ESBL-E. The results showed that despite extensive surveillance screening, almost one-third of ESBL-E carriers were not isolated, impeding timely implementation of targeted contact isolation.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Article Infectious Diseases

Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain

Juan Antonio Castillo-Polo, Marta Hernandez-Garcia, Maria Isabel Morosini, Blanca Perez-Viso, Cruz Soriano, Raul De Pablo, Rafael Canton, Patricia Ruiz-Garbajosa

Summary: The study aimed to describe the phenotypic and genotypic characteristics of ceftazidime/avibactam- and cefiderocol-resistant KPC-Klebsiella pneumoniae (KPC-Kp) during an outbreak in a medical ICU. The KPC-Kp isolates involved in the outbreak were found to belong to the high-risk clone ST307 and carried the KPC + CTX-M-15 genes. Cloning experiments showed that specific gene mutations may contribute to resistance to ceftazidime/avibactam and cefiderocol.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Medicine, General & Internal

Treatment of COVID-19 during the Acute Phase in Hospitalized Patients Decreases Post-Acute Sequelae of COVID-19

Diana Badenes Bonet, Oswaldo Antonio Caguana Velez, Xavier Duran Jorda, Merce Comas Serrano, Margarita Posso Rivera, Mireia Admetllo, Anna Herranz Blasco, Elisa Cuadrado Godia, Ester Marco Navarro, Gemma Martin Ezquerra, Zenaida Pineiro Aguin, Maria Cinta Cumpli Gargallo, Jose Gregorio Gonzalez Garcia, Eva Balcells Vilarnau, Diego Rodriguez Chiaradia, Xavier Castells, Joaquim Gea, Juan P. Horcajada, Judit Villar-Garcia

Summary: This study aimed to identify risk factors for the presence of post-acute sequelae of SARS-CoV-2 (PASC) and describe the profile of persistent symptoms in a multidisciplinary Post-Coronavirus Disease-19 (COVID-19) Unit. The results showed that treatment with dexamethasone and remdesivir was associated with shorter duration of symptoms, and female gender, obesity, asthma, and disease severity were identified as risk factors for PASC.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Microbiology

Antimicrobial Resistance in the Global Health Network: Known Unknowns and Challenges for Efficient Responses in the 21st Century

Teresa M. Coque, Rafael Canton, Ana Elena Perez-Cobas, Miguel D. Fernandez-de-Bobadilla, Fernando Baquero

Summary: Antimicrobial resistance (AMR) is a global health challenge that has been studied and approached from various perspectives, including patient safety, molecular epidemiology, public health, health economics, community psychology, and history of science. However, there is a lack of dialogue between different stakeholders, hindering the development and implementation of effective strategies to combat AMR.

MICROORGANISMS (2023)

Article Infectious Diseases

Antimicrobial surveillance: A 20-year history of the SMART approach to addressing global antimicrobial resistance into the future

Rafael Canton, Thomas Gottlieb, Geoffrey W. Coombs, Patrick C. Y. Woo, Tony M. Korman, Maria Garcia-Castillo, Denise Daley, Karri A. Bauer, Michael Wong, Dominik J. Wolf, Fakhar Siddiqui, Mary Motyl

Summary: Antimicrobial resistance (AMR) is a major global public health threat, particularly affecting patients in resource-poor settings. Various surveillance programs exist worldwide, and one of the largest is the SMART program, which has been running for 20 years. The SMART database includes data from nearly 500,000 isolates from over 60 countries, and can help monitor and guide clinical treatment.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)

Review Medicine, General & Internal

Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review

Francisco Javier Candel, Miguel Salavert, Miren Basaras, Marcio Borges, Rafael Canton, Emilia Cercenado, Catian Cilloniz, Angel Estella, Juan M. Garcia-Lechuz, Jose Garnacho Montero, Federico Gordo, Agustin Julian-Jimenez, Francisco Javier Martin-Sanchez, Emilio Maseda, Mayra Matesanz, Rosario Menendez, Manuel Miron-Rubio, Raul Ortiz de Lejarazu, Eva Polverino, Pilar Retamar-Gentil, Luis Alberto Ruiz-Iturriaga, Susana Sancho, Leyre Serrano

Summary: This paper reviews important issues in the approach to community-acquired pneumonia, including updates in etiology, diagnostic guidance, treatment, management, and prevention.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Health Care Sciences & Services

Clinical, Microbiological and Treatment Characteristics of Severe Postoperative Respiratory Infections: An Observational Cohort Study

Adela Benitez-Cano, Silvia Bermejo, Sonia Luque, Luisa Sorli, Jesus Carazo, Irene Zaragoza, Isabel Ramos, Jordi Valles, Juan P. Horcajada, Ramon Adalia

Summary: This study evaluated the clinical, microbiological, and treatment characteristics of severe postoperative pneumonia and tracheobronchitis. The findings showed that surgical patients are at high risk for early onset severe pneumonia and tracheobronchitis, with a high proportion of Gram-negative and multi-drug resistant bacteria.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Health Care Sciences & Services

Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis

Miquel Angel Sastre-Femenia, Almudena Fernandez-Munoz, Maria Antonia Gomis-Font, Biel Taltavull, Carla Lopez-Causape, Jorge Arca-Suarez, Luis Martinez-Martinez, Rafael Canton, Nieves Larrosa, Jesus Oteo-Iglesias, Laura Zamorano, Antonio Oliver

Summary: A high-resolution analysis of resistance patterns, genomic epidemiology, and resistome of Pseudomonas aeruginosa in Spain over a five-year period reveals a general decrease in resistance but an increase in the proportion of XDR strains producing carbapenemases, with the high-risk clone ST235 becoming more prevalent.

LANCET REGIONAL HEALTH-EUROPE (2023)

暂无数据